InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,187.70
(
0.13%
)
US TECH 100
17,607.60
(
-0.03%
)
Dow Jones
38,884.26
(
0.08%
)
Brent Oil
82.32
(
-0.66%
)
Bitcoin
62,475.05
(
0.23%
)
Post# of 23979
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

BioSpecialist

Send PM Follow Ignore
Followers 129
Posts 2150
Boards Moderated 1
Alias Born 12/27/2007

BioSpecialist

Re: None

Friday, 01/13/2017 10:25:03 AM

Friday, January 13, 2017 10:25:03 AM

Post# of 23979
NEOS (MC $95 M) $60 M Cash 1 Drug approved 2 more under review by FDA targeting Billion Dollar Markets .

Very attractive and unknown FDA play with HUGE upside Potential i see thefair value around $20 per share .GL


NEOS Therapeutics (NEOS)

Market Cap: $95 M
Cash: $60 M
Price $6

Shares Out: 16.06 M

Presentation
http://investors.neostx.com/phoenix.zhtml?c=254075&p=irol-presentations

•Adzenys XR-ODT launched May, 2016
•Robust prescription growth since launch
•22,797 total TRx through December 2, 2016

•Pipeline includes two late-stage product candidates for the treatment of ADHD

•Amphetamine XR-Oral Suspension —NDA Submitted Nov 15, 2016

•Cotempla (methylphenidate) XR-ODT —NDA resubmitted Dec 20, 2016
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up